Predicting type 2 diabetes via machine learning integration of multiple omics from human pancreatic islets
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: DIABLO/PLS multi-omics integration predicted type 2 diabetes status and identified associated biomarkers in a small cross-sectional donor sample; independent clinical validation was not established.
Technology: DIABLO/PLS multi-omics integration
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- DIABLO/PLS multi-omics integration
- Limitation / still unknown
- The result came from a small cross-sectional donor sample; independent diagnostic performance and prospective clinical utility were not established.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://europepmc.org/article/MED/38918439 · https://doi.org/10.1038/s41598-024-64846-3 · https://pubmed.ncbi.nlm.nih.gov/38918439/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.